Kiniksa Pharmaceuticals L... (KNSA)
NASDAQ: KNSA
· Real-Time Price · USD
33.36
0.08 (0.24%)
At close: Aug 15, 2025, 3:59 PM
33.38
0.06%
After-hours: Aug 15, 2025, 04:54 PM EDT
Kiniksa Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 156.8M | 137.78M | 122.54M | 112.21M | 108.63M | 79.86M | 83.39M | 67.05M | 71.47M | 48.34M | 61.88M | 99.14M | 26.97M | 32.19M | 18.75M | 12.1M | 7.7M | n/a |
Cost of Revenue | 71.02M | 61.66M | -62.23M | 49.42M | 42.45M | 31.54M | 26.76M | 26.4M | 21.68M | 7.04M | 14.23M | 11.56M | 5.03M | 4.22M | 3.87M | 2.77M | 2.47M | 883K |
Gross Profit | 85.76M | 76.13M | 184.76M | 62.8M | 66.18M | 48.32M | 56.64M | 40.65M | 49.79M | 41.31M | 47.65M | 87.58M | 21.94M | 27.97M | 14.88M | 9.33M | 5.24M | -883K |
Operating Income | 20.16M | 13.27M | -19.3M | -9.66M | -117K | -16.54M | 81K | -10.93M | -3.15M | -11.2M | 6.05M | 46.41M | -19.37M | -23.25M | -36.13M | -30.67M | -40.55M | -49.28M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 2.37M | 2.43M | 1.92M | 1.83M | 794K | 322K | 103K | 34K | 77K | 5K | 6K | 9K |
Pretax Income | 22.88M | 15.56M | -16.98M | -7.2M | 2.3M | -14.28M | 2.45M | -8.5M | -1.24M | -9.36M | 6.84M | 46.73M | -19.27M | -23.29M | -36.05M | -30.66M | -40.55M | -49.27M |
Net Income | 17.83M | 8.54M | -8.89M | -12.69M | -3.91M | -17.7M | 25.24M | -13.86M | 14.97M | -12.27M | 4.46M | 224.09M | -19.98M | -25.21M | -36.33M | -30.54M | -41.56M | -49.48M |
Selling & General & Admin | 46.86M | 43.53M | 40.53M | 46.4M | 42.4M | 38.68M | 36.74M | 34.47M | 29.18M | 29.05M | 27.21M | 24.68M | 23.84M | 22.22M | 22.74M | 20.76M | 21.85M | 20.6M |
Research & Development | 18.75M | 19.32M | 35.22M | 26.06M | 23.9M | 26.18M | 19.82M | 17.11M | 23.77M | 15.17M | 14.39M | 16.48M | 13.8M | 20.82M | 27.43M | 19.24M | 23.95M | 28.68M |
Other Expenses | 71.02M | n/a | 128.31M | n/a | n/a | n/a | n/a | n/a | n/a | 8.29M | n/a | n/a | 3.67M | 8.25M | 835K | n/a | n/a | n/a |
Operating Expenses | 136.64M | 62.85M | 204.06M | 72.46M | 66.29M | 64.86M | 56.55M | 51.57M | 52.94M | 52.51M | 41.6M | 41.16M | 41.31M | 51.29M | 51.01M | 39.99M | 45.79M | 49.28M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 1.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 124.51M | 141.84M | 121.87M | 108.75M | 96.4M | 83.31M | 77.97M | 74.63M | 59.54M | 55.84M | 52.72M | 46.34M | 55.51M | 54.88M | 42.76M | 48.26M | 49.28M |
Income Tax Expense | -5.04M | 7.03M | -8.09M | 5.49M | 6.21M | 3.43M | -22.79M | 5.36M | -16.21M | 2.91M | 2.38M | -177.36M | 716K | 1.93M | 279K | -118K | 1.01M | 210K |
Shares Outstanding (Basic) | 73.44M | 72.65M | 72.32M | 71.73M | 71M | 70.63M | 70.37M | 70.19M | 69.92M | 69.75M | 69.61M | 69.45M | 68.9M | 69.14M | 68.97M | 68.66M | 68.14M | 68.27M |
Shares Outstanding (Diluted) | 77.94M | 76.15M | 72.32M | 71.73M | 71M | 70.63M | 72.66M | 70.19M | 71.63M | 69.75M | 71.37M | 70.55M | 69.29M | 69.14M | 68.97M | 68.66M | 68.4M | 68.27M |
EPS (Basic) | 0.24 | 0.12 | -0.12 | -0.18 | -0.06 | -0.25 | 0.36 | -0.2 | 0.21 | -0.18 | 0.06 | 3.23 | -0.29 | -0.36 | -0.53 | -0.44 | -0.61 | -0.72 |
EPS (Diluted) | 0.23 | 0.11 | -0.12 | -0.18 | -0.06 | -0.25 | 0.35 | -0.2 | 0.21 | -0.18 | 0.06 | 3.18 | -0.29 | -0.36 | -0.53 | -0.44 | -0.61 | -0.72 |
EBITDA | 20.16M | 13.62M | -18.9M | -9.26M | 313K | -16.08M | 317K | -10.32M | -2.55M | -10.6M | 7.92M | 46.41M | -18.72M | -22.66M | -35.46M | -30.01M | -39.84M | -48.97M |
EBIT | 22.88M | 13.27M | -19.3M | -9.66M | -117K | -16.54M | 2.45M | -10.93M | -3.15M | -11.2M | 6.84M | 46.73M | -19.37M | -23.32M | -36.13M | -30.67M | -40.55M | -49.28M |
Depreciation & Amortization | n/a | 345K | 400K | 399K | 430K | 466K | 236K | 999K | 1.06M | 1.13M | 1.08M | 949K | 1.1M | 1.09M | 1.11M | 1.07M | 1.02M | 883K |